"MLV & Co Initiates Coverage On pSivida On Multiple Positive Factors"
US$6 target
Read more:
http://www.benzinga.com/analyst-ratings/analyst-color/14/05/4524799/update-mlv-co-initiates-coverage-on-psivida-on-multiple-#ixzz30saBsj3f
Also "pSivida Presents Preclinical Data Demonstrating Sustained Release of Avastin Using Tethadur at ARVO Annual Meeting"
http://psdv.client.shareholder.com/releasedetail.cfm?ReleaseID=845304
Add to My Watchlist
What is My Watchlist?